On drug costs, modest steps follow Trump's big promises
President Donald Trump makes big promises to reduce prescription drug costs, but his administration is gravitating to relatively modest steps such as letting Medicare patients share in manufacturer rebates.
Recalls this week: laptops, chairs, lamp sockets
More than 80,000 laptops with a potentially defective battery are among this week's recalled consumer products.
Pepsi launches new sparkling water line
PepsiCo unveils new sparkling-water line called bubly.
The 5 countries with the best healthcare in the world for retirees
There are places overseas where retirees can enjoy excellent-quality healthcare—as good if not better than what they expect in the US for pennies on the dollar.
Trump proposes reduction of drug costs under Medicare
President Donald Trump will propose lowering prescription drug costs for Medicare beneficiaries by allowing them to share in rebates that drug companies pay to insurers and middlemen, an administration official said.
Trump aims to reduce drug costs under Medicare
Drug companies would bear a bigger share of Medicare's costs under the congressional budget deal, a shift that could help limit future increases in beneficiaries' premiums for prescription coverage.
Trump to propose reducing some prescription drug costs for Medicare beneficiaries
Trump to propose reducing some prescription drug costs for Medicare beneficiaries.
The Latest: Trump aims to reduce drug costs under Medicare
The Latest on proposals by President Donald Trump and in the Senate budget bill to lower drug prices for Medicare beneficiaries (all times local): 9 p.m. President Donald Trump is proposing to lower prescription drug costs for Medicare beneficiaries by allowing them to share in rebates that drug companies pay to insurers and other middlemen.
Teva chief reports 'strong progress' in restructuring plan
The chief executive of Teva Pharmaceuticals says he is making "strong progress" on the company's restructuring plan, but has acknowledged the generic drug giant faces a challenging 2018.
Opioid epidemic is the deadliest drug crisis in US history: AG Sessions
Opioid crisis ripple effect
Former GE CEO Jeff Immelt named chairman of Athenahealth
The appointment is not the first for Mr. Immelt since his departure last year from GE, where he spent 16 years as CEO.
For 3rd time, General Motors seeks to avoid Takata recalls
For the third time in the past three years, General Motors has asked the U.S. government for permission to avoid recalls of potentially deadly Takata air bag inflators.
LA Times buyer is a basketball-loving biotech billionaire
The man buying the Los Angeles Times is a 65-year-old physician-entrepreneur described by Forbes Magazine as "America's richest doctor."
Harley recalls over 250K bikes globally; brakes can fail
Under pressure from U.S. safety regulators, Harley-Davidson is recalling nearly 175,000 motorcycles because the brakes might fail.
GSK cheers investors with asthma drug sales, big dividend
Drugmaker GlaxoSmithKline sank to a fourth-quarter loss of 546 million pounds ($758 million) from a profit of 257 million pounds a year earlier, as it dealt with U.S. tax changes.
Higher menu prices help Chipotle key sales figure
Chipotle, which has been struggling to turn its business around after a series of food safety scares, said a key sales figure rose in the fourth quarter as it raised menu prices.
Allergan's profit beats; migraine drug succeeds in key study
The drugmaker said patients on its treatment were relieved of pain after two hours, and did not experience migraine symptoms compared to a placebo.
Flu increases your risk of a heart attack?
The severe flu season
Greek govt alleges official ties to drug bribery scandal
Greece's government says it has evidence that senior politicians from the previous administration were involved in a bribery case in which Swiss drugmaker Novartis is accused of making illegal payments to fix prices and increase market access.
British officials condemn Trump remarks on UK health care
President Donald Trump is citing protests over health care funding in Britain to attack Democrats for "pushing for Universal HealthCare."












